Literature DB >> 29770796

Suppression of MIF-induced neuronal apoptosis may underlie the therapeutic effects of effective components of Fufang Danshen in the treatment of Alzheimer's disease.

Cheng-Jie Liang1,2, Jia-Huang Li1, Zhen Zhang1, Ju-Yan Zhang1, Shu-Qun Liu3, Jie Yang4,5.   

Abstract

Fufang Danshen (FFDS or Compound Danshen) consists of three Chinese herbs Danshen (Salviae miltiorrhizae radix et rhizome), Sanqi (Notoginseng radix et rhizome) and Tianranbingpian (Borneolum, or D-borneol), which has been show to significantly improve the function of the nervous system and brain metabolism. In this study we explored the possible mechanisms underlying the therapeutic effects of the combination of the effective components of FFDS (Tan IIA, NG-R1 and Borneol) in the treatment of Alzheimer's disease (AD) based on network pharmacology. We firstly constructed AD-related FFDS component protein interaction networks, and revealed that macrophage migration inhibitory factor (MIF) might regulate neuronal apoptosis through Bad in the progression of AD. Then we investigated the apoptosis-inducing effects of MIF and the impact of the effective components of FFDS in human neuroblastoma SH-SY5Y cells. We observed the characteristics of a "Pendular state" of MIF, where MIF (8 ng/mL) increased the ratio of p-Bad/Bad by activating Akt and the IKKα/β signaling pathway to assure cell survival, whereas MIF (50 ng/mL) up-regulated the expression of Bad to trigger apoptosis of SH-SY5Y cells. MIF displayed neurotoxicity similar to Aβ1-42, which was associated with the MIF-induced increased expression of Bad. Application of the FFDS composite solution significantly decreased the expression levels of Bad, suppressed MIF-induced apoptosis in SH-SY5Y cells. In a D-galactose- and AlCl3-induced AD mouse model, administration of the FFDS composite solution significantly improved the learning and memory, as well as neuronal morphology, and decreased the serum levels of INF-γ. Therefore, the FFDS composite solution exerts neuroprotective effects through down-regulating the level of Bad stimulated by MIF.

Entities:  

Keywords:  Alzheimer′s disease; Bcl-2 family proteins; Fang Danshen; MIF; SH-SY5Y cells; apoptosis; learning and memory; neuroprotection; traditional Chinese medicine

Mesh:

Substances:

Year:  2018        PMID: 29770796      PMCID: PMC6289349          DOI: 10.1038/aps.2017.210

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  54 in total

1.  The human disease network.

Authors:  Kwang-Il Goh; Michael E Cusick; David Valle; Barton Childs; Marc Vidal; Albert-László Barabási
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

2.  The role of macrophage migration inhibitory factor in Alzheimer's disease.

Authors:  Michael Bacher; Oliver Deuster; Bayan Aljabari; Rupert Egensperger; Frauke Neff; Frank Jessen; Julius Popp; Carmen Noelker; Jens Peter Reese; Yousef Al-Abed; Richard Dodel
Journal:  Mol Med       Date:  2010-02-28       Impact factor: 6.354

3.  Molecular network-based analysis of guizhi-shaoyao-zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy.

Authors:  Ning Zhao; Jian Li; Li Li; Xu-yan Niu; Miao Jiang; Xiao-juan He; Zhao-xiang Bian; Ge Zhang; Ai-ping Lu
Journal:  Acta Pharmacol Sin       Date:  2015-04-27       Impact factor: 6.150

4.  IKKβ deficiency in myeloid cells ameliorates Alzheimer's disease-related symptoms and pathology.

Authors:  Yang Liu; Xu Liu; Wenlin Hao; Yann Decker; Robert Schomburg; Livia Fülöp; Manolis Pasparakis; Michael D Menger; Klaus Fassbender
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

Review 5.  Alzheimer's disease.

Authors:  Vanessa J De-Paula; Marcia Radanovic; Breno S Diniz; Orestes V Forlenza
Journal:  Subcell Biochem       Date:  2012

6.  β-Amyloid (Aβ) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1.

Authors:  Wayne W Poon; Anthony J Carlos; Brittany L Aguilar; Nicole C Berchtold; Crystal K Kawano; Vahe Zograbyan; Tim Yaopruke; Michael Shelanski; Carl W Cotman
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

7.  Inactivation of BAD by IKK inhibits TNFα-induced apoptosis independently of NF-κB activation.

Authors:  Jie Yan; Jialing Xiang; Yutin Lin; Jingui Ma; Jiyan Zhang; Hao Zhang; Jisheng Sun; Nika N Danial; Jing Liu; Anning Lin
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

8.  Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.

Authors:  Xueying Tan; Jianping Li; Xinyue Wang; Nan Chen; Benzhi Cai; Gang Wang; Hongli Shan; Deli Dong; Yanju Liu; Xingda Li; Fan Yang; Xin Li; Peng Zhang; Xueqi Li; Baofeng Yang; Yanjie Lu
Journal:  Int J Biol Sci       Date:  2011-04-07       Impact factor: 6.580

9.  Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.

Authors:  Shu-Qin Li; Yang Yu; Jin-Zhao Han; Ding Wang; Jin Liu; Feng Qian; Guo-Huang Fan; Richard Bucala; Richard D Ye
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

10.  Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer's disease.

Authors:  Min Liu; Haibiao Guo; Chuyuan Li; Deqin Wang; Jingang Wu; Canmao Wang; Jiangping Xu; Ren-An Qin
Journal:  BMC Complement Altern Med       Date:  2015-10-23       Impact factor: 3.659

View more
  8 in total

1.  Mining of candidate genes involved in the biosynthesis of dextrorotatory borneol in Cinnamomum burmannii by transcriptomic analysis on three chemotypes.

Authors:  Zerui Yang; Wenli An; Shanshan Liu; Yuying Huang; Chunzhu Xie; Song Huang; Xiasheng Zheng
Journal:  PeerJ       Date:  2020-06-10       Impact factor: 2.984

Review 2.  The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease: Conventionally Pathogenetic or Unconventionally Protective?

Authors:  Maria Cristina Petralia; Giuseppe Battaglia; Valeria Bruno; Manuela Pennisi; Katia Mangano; Salvo Danilo Lombardo; Paolo Fagone; Eugenio Cavalli; Andrea Saraceno; Ferdinando Nicoletti; Maria Sofia Basile
Journal:  Molecules       Date:  2020-01-10       Impact factor: 4.411

3.  Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis.

Authors:  Yawen Cai; Yuhui Chai; Yu Fu; Yingdi Wang; Yiming Zhang; Xue Zhang; Lingpeng Zhu; Mingxing Miao; Tianhua Yan
Journal:  Front Aging Neurosci       Date:  2022-01-21       Impact factor: 5.750

Review 4.  The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer's Disease.

Authors:  Gilbert Ogunmokun; Saikat Dewanjee; Pratik Chakraborty; Chandrasekhar Valupadas; Anupama Chaudhary; Viswakalyan Kolli; Uttpal Anand; Jayalakshmi Vallamkondu; Parul Goel; Hari Prasad Reddy Paluru; Kiran Dip Gill; P Hemachandra Reddy; Vincenzo De Feo; Ramesh Kandimalla
Journal:  Cells       Date:  2021-10-18       Impact factor: 6.600

5.  Exercise inhibits JNK pathway activation and lipotoxicity via macrophage migration inhibitory factor in nonalcoholic fatty liver disease.

Authors:  Ni Cui; Hui Li; Yaoshan Dun; Jeffrey W Ripley-Gonzalez; Baiyang You; Dezhao Li; Yuan Liu; Ling Qiu; Cui Li; Suixin Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

Review 6.  Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2021       Impact factor: 1.990

Review 7.  Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1.

Authors:  Kenneth Maiese
Journal:  Neural Regen Res       Date:  2021-03       Impact factor: 5.135

Review 8.  Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.

Authors:  Kevin Zhai; Aranka Brockmüller; Peter Kubatka; Mehdi Shakibaei; Dietrich Büsselberg
Journal:  Biomolecules       Date:  2020-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.